NasdaqGM - Delayed Quote USD
Silence Therapeutics plc (SLN)
At close: October 4 at 4:00 PM EDT
After hours: October 4 at 4:00 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SLN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.20% |
| Next Qtr. | -- | -- | -- | 9.30% |
| Current Year | -- | -- | -- | 3.10% |
| Next Year | -- | -- | -- | 12.70% |
| Next 5 Years (per annum) | -- | -- | -- | 11.91% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/30/2024 |
| Maintains | Chardan Capital: Buy to Buy | 8/16/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 6/28/2024 |
| Maintains | Chardan Capital: Buy to Buy | 6/28/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/27/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/20/2024 |
Related Tickers
TCRX TScan Therapeutics, Inc.
5.51
+4.36%
SRRK Scholar Rock Holding Corporation
7.42
+4.95%
SYRE Spyre Therapeutics, Inc.
29.15
+2.75%
RLYB Rallybio Corporation
1.1100
+0.91%
KROS Keros Therapeutics, Inc.
60.90
+1.67%
DNTH Dianthus Therapeutics, Inc.
28.00
+1.97%
KYMR Kymera Therapeutics, Inc.
43.06
-0.81%
TYRA Tyra Biosciences, Inc.
22.04
+2.13%
CALC CalciMedica, Inc.
4.3586
+2.80%
LRMR Larimar Therapeutics, Inc.
6.65
+1.99%